4 results
The objective of this study is to collect additional data on the safety and performance of the slowly-resorbable TIGR® mesh in patients undergoing TEP for IGRP.
To provide proof of concept that POWER2DM is safe and effective in improving glycaemic control and analyse of the cost-effectiveness of the approach to highlight any potential issues that may impede implementation.
The objective of this study is to collect additional data on the performance and safety of the slowly-resorbable TIGR® mesh in patients undergoing TEP for IGRP. The study endpoints are described below.
To investigate the feasibility of skin perfusion measurements of lower limb tissue in 20 PAOD patients with continuous ICG-VA. Feasibility is defined as the ability to detect hypo perfusion in the diseased leg in comparison with the patient's…